Product Description

With our immense industrial experience, we are engaged in offering Solution Injectable Mecasermine, which is used to treat children and adolescents from 2 to 18 years old who are very short for their age because their bodies do not make enough IGF-1. This is indicated for the treatment of growth failure in children with severe primary IGF-1 deficiency. In addition to this, the Solution Injectable Mecasermine offered by us can be availed by our valuable clients at market leading prices.